During the past decade, Städtisches Klinikum München conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Städtisches Klinikum München" #1 sponsor was "Abbott Medical Devices" with 1 trials, followed by "Amgen" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "CTI BioPharma" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Städtisches Klinikum München" #1 collaborator was "ARMO BioSciences" with 1 trials as a collaborator, "Edwards Lifesciences" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Städtisches Klinikum München" are "Aortic Valve Stenosis" (1 trials), "Atrial Fibrillation" (1 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Blincyto Use in Routine Clinical Practice" (1 trials) and "Carcinoma" (1 trials). Many other conditions were trialed in "Städtisches Klinikum München" in a lesser frequency.

Most popular intervention types in "Städtisches Klinikum München" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Best Available Therapy" (1 trials), "Clopidogrel or Ticagrelor" (1 trials), "Dabigatran Etexilate 110mg" (1 trials) and "Dabigatran Etexilate 150mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Städtisches Klinikum München" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Städtisches Klinikum München". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Städtisches Klinikum München, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Städtisches Klinikum München, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Städtisches Klinikum München has several departments that took part in Clinical trials: "Klinikum der LMU München; Klinik und Poliklinik für Dermatologie und Allergologie" - 4 trials, "Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie" - 2 trials, "Staedtisches Krankenhaus Muenchen-Schwabing, Haematologie & Onkolgie" - 2 trials, "Klinikum Schwabing, Kinderklinik der TU Päd. Hämatologie / Onkologie, Station 24d" - 2 trials, "Klinikum Bogenhausen; Klinik für Pneumologie und Pneumologische Onkologie" - 2 trials, "Klinik für Hämatologie, Onkologie, Immunologie" - 2 trials